Avicanna Stock Today
| AVCN Stock | CAD 0.27 0.01 3.85% |
Performance0 of 100
| Odds Of DistressLess than 49
|
Avicanna is selling at 0.27 as of the 21st of November 2024; that is 3.85 percent increase since the beginning of the trading day. The stock's open price was 0.26. Avicanna has 49 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Avicanna are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of October 2024 and ending today, the 21st of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Avicanna Inc. focuses on the research and development, cultivation, manufacture, and commercialization of plant-derived cannabinoid-based products and extracts in North America, Latin America, Europe, and Asia. The company was founded in 2016 and is headquartered in Toronto, Canada. The company has 109.57 M outstanding shares of which 303.15 K shares are presently shorted by private and institutional investors with about 1.26 days to cover all short positions. More on Avicanna
Moving against Avicanna Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Avicanna Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Avicanna's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Avicanna or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) | ||||
Avicanna's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Avicanna's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAvicanna can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Avicanna's financial leverage. It provides some insight into what part of Avicanna's total assets is financed by creditors.
| |||||
Avicanna (AVCN) is traded on Toronto Exchange in Canada and employs 87 people. Avicanna is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 27.94 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Avicanna's market, we take the total number of its shares issued and multiply it by Avicanna's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Avicanna operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 109.57 M outstanding shares of which 303.15 K shares are presently shorted by private and institutional investors with about 1.26 days to cover all short positions.
Avicanna has accumulated about 12.98 M in cash with (1.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.66, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Avicanna Probability Of Bankruptcy
Ownership AllocationAvicanna holds a total of 109.57 Million outstanding shares. Avicanna retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Avicanna Ownership Details
Avicanna Risk Profiles
Although Avicanna's alpha and beta are two of the key measurements used to evaluate Avicanna's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.53 | |||
| Standard Deviation | 7.13 | |||
| Variance | 50.77 | |||
| Risk Adjusted Performance | (0.01) |
Avicanna Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Avicanna without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Avicanna Corporate Management
Elected by the shareholders, the Avicanna's board of directors comprises two types of representatives: Avicanna inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avicanna. The board's role is to monitor Avicanna's management team and ensure that shareholders' interests are well served. Avicanna's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avicanna's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ingrid Diaz | Assistant VP | Profile | |
| Mba BEcon | CEO CoFounder | Profile | |
| Arash MBA | Executive Technology | Profile | |
| Karolina Urban | Executive Affairs | Profile | |
| Roland Alvarez | SVP Operations | Profile | |
| Frantz Devedec | Executive Development | Profile | |
| Caitlin Johnston | VP Access | Profile |
Other Information on Investing in Avicanna Stock
Avicanna financial ratios help investors to determine whether Avicanna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avicanna with respect to the benefits of owning Avicanna security.